Page last updated: 2024-12-07

2-chloro-n(6)cyclopentyladenosine

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

2-chloro-N(6)cyclopentyladenosine: highly selective agonist at A1 adenosine receptors [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID123807
CHEMBL ID284969
SCHEMBL ID120439
MeSH IDM0162853

Synonyms (43)

Synonym
brn 4888162
2-chloro-n(6)cyclopentyladenosine
adenosine, 2-chloro-n-cyclopentyl-
2-chloro-n6-cyclopentyladenosine
[3h]-ccpa
2-chloro-n6-cyclopentyladenosine (2-cl-cpa)
gtpl379
[3h]ccpa
gtpl374
PDSP1_000305
PDSP2_000818
PDSP1_001070
PDSP2_001054
ccpa
2-chloro-n6-cyclopentyladenosine, adenosine receptor agonist
NCGC00025266-02
PDSP1_000831
PDSP2_000303
2-(2-chloro-6-cyclopentylamino-purin-9-yl)-5-hydroxymethyl-tetrahydro-furan-3,4-diol(ccpa)
(2r,3r,4s,5r)-2-(2-chloro-6-(cyclopentylamino)-9h-purin-9-yl)-5-(hydroxymethyl)-tetrahydrofuran-3,4-diol
(2r,3r,4s,5r)-2-(2-chloro-6-cyclopentylamino-purin-9-yl)-5-hydroxymethyl-tetrahydro-furan-3,4-diol
bdbm50085658
2-cl-cpa
n6-cyclopentyl-2-chloroado
CHEMBL284969 ,
ccpa-2-chloro-n(6)-cyclopentyladenosine
37739-05-2
(2r,3r,4s,5r)-2-[2-chloro-6-(cyclopentylamino)purin-9-yl]-5-(hydroxymethyl)oxolane-3,4-diol
2-(2-chloro-6-cyclopentylamino-purin-9-yl)-5-hydroxymethyl-tetrahydro-furan-3,4-diol
(2r,3r,4s,5r)-2-[2-chloro-6-(cyclopentylamino)purin-9-yl]-5-(hydroxymethyl)tetrahydrofuran-3,4-diol
A823848
AKOS016009595
jx2f2w6wsp ,
unii-jx2f2w6wsp
2-chloro-n-cyclopentyladenosine
SCHEMBL120439
XSMYYYQVWPZWIZ-IDTAVKCVSA-N
(2r,3r,4s,5r)-2-(2-chloro-6-(cyclopentylamino)-9h-purin-9-yl)-5-(hydroxymethyl)tetrahydrofuran-3,4-diol
HMS3676D14
HMS3412D14
Q5009685
DTXSID00958774
(2r,3r,4s,5r)-2-[2-chloro-6-(cyclopentylamino)-9h-purin-9-yl]-5-(hydroxymethyl)tetrahydrofuran-3,4-diol
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Pathways (1)

PathwayProteinsCompounds
Purinergic signaling053

Protein Targets (19)

Inhibition Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
5-hydroxytryptamine receptor 1AHomo sapiens (human)Ki0.79600.00010.532610.0000AID34717
Adenosine receptor A3Homo sapiens (human)IC50 (µMol)0.01120.00001.89408.5470AID1281005
Adenosine receptor A3Homo sapiens (human)Ki1.47050.00000.930610.0000AID1282224; AID1571898; AID1703320; AID256762; AID313265; AID32772; AID33507; AID34573; AID34574; AID34706; AID34717; AID34719; AID34733; AID34735
Adenosine receptor A1Rattus norvegicus (Norway rat)Ki0.00500.00011.20929.9700AID31855; AID31859; AID32012; AID32177; AID32179; AID32358; AID32634
Adenosine receptor A1Bos taurus (cattle)Ki0.00030.00000.71316.0000AID313255; AID32002
Adenosine receptor A3Rattus norvegicus (Norway rat)Ki0.23700.00030.91969.0000AID256764; AID33479; AID33485
Adenosine receptor A2aHomo sapiens (human)Ki1.62960.00001.06099.7920AID1571896; AID1703319; AID256761; AID313264; AID33928; AID34248; AID34681; AID34844; AID702179
Adenosine receptor A2bHomo sapiens (human)Ki10.22100.00021.635210.0000AID313266; AID33295
Adenosine receptor A2bRattus norvegicus (Norway rat)Ki0.95000.00061.353610.0000AID33901
Adenosine receptor A1Homo sapiens (human)IC50 (µMol)0.00090.00020.68187.7010AID1281004; AID30310
Adenosine receptor A1Homo sapiens (human)Ki0.00620.00020.931610.0000AID1162471; AID1571891; AID1703318; AID256760; AID30461; AID30905; AID313263; AID363482; AID703961
Adenosine receptor A2aRattus norvegicus (Norway rat)Ki0.74080.00021.494010.0000AID32863; AID32896; AID33790; AID33901; AID33939; AID33943
Delta-type opioid receptorMus musculus (house mouse)Ki0.23700.00000.53939.4000AID256764
Delta-type opioid receptorRattus norvegicus (Norway rat)Ki0.23700.00000.60689.2330AID256764
Adenylate cyclase type 5Rattus norvegicus (Norway rat)Ki0.03800.00140.04950.1180AID34574
Adenosine receptor A1Sus scrofa (pig)Ki0.00030.00030.00200.0076AID313255; AID313256
Adenosine receptor A1Mus musculus (house mouse)Ki0.00020.00010.42424.4300AID1571893
Adenosine receptor A2aMus musculus (house mouse)Ki0.98800.80803.199010.0000AID1571897
Adenosine receptor A3Mus musculus (house mouse)Ki0.01700.00010.90956.3600AID1571899
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Activation Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Adenosine receptor A1Rattus norvegicus (Norway rat)EC50 (µMol)1.64960.00161.04608.2000AID1571971; AID224979; AID31261; AID31265; AID31266
Adenosine receptor A2aHomo sapiens (human)EC50 (µMol)10.00000.00030.708110.0000AID1280986
Adenosine receptor A2bHomo sapiens (human)EC50 (µMol)72.44360.00030.946110.0000AID1280987
Adenosine receptor A1Homo sapiens (human)EC50 (µMol)0.07270.00010.99169.8000AID1280985; AID699043; AID699044
Adenosine receptor A2aRattus norvegicus (Norway rat)EC50 (µMol)0.01000.00000.11560.7200AID33769
Adenosine receptor A1Mus musculus (house mouse)EC50 (µMol)0.01770.01770.01770.0177AID759401
Cannabinoid receptor 2Rattus norvegicus (Norway rat)EC50 (µMol)0.00460.00030.06660.3150AID699043
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Other Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
interferon gamma precursorHomo sapiens (human)AC5039.00000.128015.173038.6100AID1259420
Adenosine receptor A2bRattus norvegicus (Norway rat)Ratio0.95000.00330.82929.6000AID33746
Adenosine receptor A2aRattus norvegicus (Norway rat)Ratio0.95000.00330.82309.6000AID33746
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Biological Processes (119)

Processvia Protein(s)Taxonomy
behavioral fear response5-hydroxytryptamine receptor 1AHomo sapiens (human)
G protein-coupled receptor signaling pathway5-hydroxytryptamine receptor 1AHomo sapiens (human)
adenylate cyclase-inhibiting serotonin receptor signaling pathway5-hydroxytryptamine receptor 1AHomo sapiens (human)
serotonin receptor signaling pathway5-hydroxytryptamine receptor 1AHomo sapiens (human)
gamma-aminobutyric acid signaling pathway5-hydroxytryptamine receptor 1AHomo sapiens (human)
positive regulation of cell population proliferation5-hydroxytryptamine receptor 1AHomo sapiens (human)
regulation of serotonin secretion5-hydroxytryptamine receptor 1AHomo sapiens (human)
regulation of vasoconstriction5-hydroxytryptamine receptor 1AHomo sapiens (human)
exploration behavior5-hydroxytryptamine receptor 1AHomo sapiens (human)
regulation of dopamine metabolic process5-hydroxytryptamine receptor 1AHomo sapiens (human)
serotonin metabolic process5-hydroxytryptamine receptor 1AHomo sapiens (human)
regulation of hormone secretion5-hydroxytryptamine receptor 1AHomo sapiens (human)
regulation of behavior5-hydroxytryptamine receptor 1AHomo sapiens (human)
chemical synaptic transmission5-hydroxytryptamine receptor 1AHomo sapiens (human)
G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger5-hydroxytryptamine receptor 1AHomo sapiens (human)
inflammatory responseAdenosine receptor A3Homo sapiens (human)
signal transductionAdenosine receptor A3Homo sapiens (human)
activation of adenylate cyclase activityAdenosine receptor A3Homo sapiens (human)
regulation of heart contractionAdenosine receptor A3Homo sapiens (human)
negative regulation of cell population proliferationAdenosine receptor A3Homo sapiens (human)
response to woundingAdenosine receptor A3Homo sapiens (human)
regulation of norepinephrine secretionAdenosine receptor A3Homo sapiens (human)
negative regulation of cell migrationAdenosine receptor A3Homo sapiens (human)
negative regulation of NF-kappaB transcription factor activityAdenosine receptor A3Homo sapiens (human)
presynaptic modulation of chemical synaptic transmissionAdenosine receptor A3Homo sapiens (human)
G protein-coupled adenosine receptor signaling pathwayAdenosine receptor A3Homo sapiens (human)
G protein-coupled adenosine receptor signaling pathwayAdenosine receptor A1Bos taurus (cattle)
response to purine-containing compoundAdenosine receptor A1Bos taurus (cattle)
synaptic transmission, dopaminergicAdenosine receptor A2aHomo sapiens (human)
response to amphetamineAdenosine receptor A2aHomo sapiens (human)
regulation of DNA-templated transcriptionAdenosine receptor A2aHomo sapiens (human)
phagocytosisAdenosine receptor A2aHomo sapiens (human)
apoptotic processAdenosine receptor A2aHomo sapiens (human)
inflammatory responseAdenosine receptor A2aHomo sapiens (human)
cellular defense responseAdenosine receptor A2aHomo sapiens (human)
adenylate cyclase-modulating G protein-coupled receptor signaling pathwayAdenosine receptor A2aHomo sapiens (human)
adenylate cyclase-activating G protein-coupled receptor signaling pathwayAdenosine receptor A2aHomo sapiens (human)
protein kinase C-activating G protein-coupled receptor signaling pathwayAdenosine receptor A2aHomo sapiens (human)
cell-cell signalingAdenosine receptor A2aHomo sapiens (human)
synaptic transmission, cholinergicAdenosine receptor A2aHomo sapiens (human)
central nervous system developmentAdenosine receptor A2aHomo sapiens (human)
blood coagulationAdenosine receptor A2aHomo sapiens (human)
sensory perceptionAdenosine receptor A2aHomo sapiens (human)
locomotory behaviorAdenosine receptor A2aHomo sapiens (human)
blood circulationAdenosine receptor A2aHomo sapiens (human)
negative regulation of cell population proliferationAdenosine receptor A2aHomo sapiens (human)
response to xenobiotic stimulusAdenosine receptor A2aHomo sapiens (human)
response to inorganic substanceAdenosine receptor A2aHomo sapiens (human)
positive regulation of glutamate secretionAdenosine receptor A2aHomo sapiens (human)
positive regulation of acetylcholine secretion, neurotransmissionAdenosine receptor A2aHomo sapiens (human)
regulation of norepinephrine secretionAdenosine receptor A2aHomo sapiens (human)
response to purine-containing compoundAdenosine receptor A2aHomo sapiens (human)
response to caffeineAdenosine receptor A2aHomo sapiens (human)
positive regulation of synaptic transmission, GABAergicAdenosine receptor A2aHomo sapiens (human)
synaptic transmission, glutamatergicAdenosine receptor A2aHomo sapiens (human)
positive regulation of urine volumeAdenosine receptor A2aHomo sapiens (human)
vasodilationAdenosine receptor A2aHomo sapiens (human)
eating behaviorAdenosine receptor A2aHomo sapiens (human)
negative regulation of vascular permeabilityAdenosine receptor A2aHomo sapiens (human)
negative regulation of neuron apoptotic processAdenosine receptor A2aHomo sapiens (human)
positive regulation of circadian sleep/wake cycle, sleepAdenosine receptor A2aHomo sapiens (human)
negative regulation of alpha-beta T cell activationAdenosine receptor A2aHomo sapiens (human)
astrocyte activationAdenosine receptor A2aHomo sapiens (human)
neuron projection morphogenesisAdenosine receptor A2aHomo sapiens (human)
positive regulation of protein secretionAdenosine receptor A2aHomo sapiens (human)
negative regulation of inflammatory responseAdenosine receptor A2aHomo sapiens (human)
regulation of mitochondrial membrane potentialAdenosine receptor A2aHomo sapiens (human)
membrane depolarizationAdenosine receptor A2aHomo sapiens (human)
regulation of calcium ion transportAdenosine receptor A2aHomo sapiens (human)
positive regulation of synaptic transmission, glutamatergicAdenosine receptor A2aHomo sapiens (human)
excitatory postsynaptic potentialAdenosine receptor A2aHomo sapiens (human)
inhibitory postsynaptic potentialAdenosine receptor A2aHomo sapiens (human)
prepulse inhibitionAdenosine receptor A2aHomo sapiens (human)
apoptotic signaling pathwayAdenosine receptor A2aHomo sapiens (human)
presynaptic modulation of chemical synaptic transmissionAdenosine receptor A2aHomo sapiens (human)
positive regulation of long-term synaptic potentiationAdenosine receptor A2aHomo sapiens (human)
positive regulation of apoptotic signaling pathwayAdenosine receptor A2aHomo sapiens (human)
G protein-coupled adenosine receptor signaling pathwayAdenosine receptor A2aHomo sapiens (human)
G protein-coupled adenosine receptor signaling pathwayAdenosine receptor A2bHomo sapiens (human)
positive regulation of chronic inflammatory response to non-antigenic stimulusAdenosine receptor A2bHomo sapiens (human)
G protein-coupled receptor signaling pathwayAdenosine receptor A2bHomo sapiens (human)
activation of adenylate cyclase activityAdenosine receptor A2bHomo sapiens (human)
positive regulation of vascular endothelial growth factor productionAdenosine receptor A2bHomo sapiens (human)
positive regulation of cGMP-mediated signalingAdenosine receptor A2bHomo sapiens (human)
cGMP-mediated signalingAdenosine receptor A2bHomo sapiens (human)
positive regulation of chemokine productionAdenosine receptor A2bHomo sapiens (human)
positive regulation of interleukin-6 productionAdenosine receptor A2bHomo sapiens (human)
mast cell degranulationAdenosine receptor A2bHomo sapiens (human)
positive regulation of mast cell degranulationAdenosine receptor A2bHomo sapiens (human)
relaxation of vascular associated smooth muscleAdenosine receptor A2bHomo sapiens (human)
presynaptic modulation of chemical synaptic transmissionAdenosine receptor A2bHomo sapiens (human)
adenylate cyclase-activating G protein-coupled receptor signaling pathwayAdenosine receptor A2bHomo sapiens (human)
vasodilationAdenosine receptor A2bHomo sapiens (human)
temperature homeostasisAdenosine receptor A1Homo sapiens (human)
response to hypoxiaAdenosine receptor A1Homo sapiens (human)
G protein-coupled adenosine receptor signaling pathwayAdenosine receptor A1Homo sapiens (human)
regulation of respiratory gaseous exchange by nervous system processAdenosine receptor A1Homo sapiens (human)
negative regulation of acute inflammatory responseAdenosine receptor A1Homo sapiens (human)
negative regulation of leukocyte migrationAdenosine receptor A1Homo sapiens (human)
positive regulation of peptide secretionAdenosine receptor A1Homo sapiens (human)
positive regulation of systemic arterial blood pressureAdenosine receptor A1Homo sapiens (human)
negative regulation of systemic arterial blood pressureAdenosine receptor A1Homo sapiens (human)
regulation of glomerular filtrationAdenosine receptor A1Homo sapiens (human)
protein targeting to membraneAdenosine receptor A1Homo sapiens (human)
phagocytosisAdenosine receptor A1Homo sapiens (human)
inflammatory responseAdenosine receptor A1Homo sapiens (human)
signal transductionAdenosine receptor A1Homo sapiens (human)
adenylate cyclase-inhibiting G protein-coupled receptor signaling pathwayAdenosine receptor A1Homo sapiens (human)
cell-cell signalingAdenosine receptor A1Homo sapiens (human)
nervous system developmentAdenosine receptor A1Homo sapiens (human)
negative regulation of cell population proliferationAdenosine receptor A1Homo sapiens (human)
response to inorganic substanceAdenosine receptor A1Homo sapiens (human)
negative regulation of glutamate secretionAdenosine receptor A1Homo sapiens (human)
response to purine-containing compoundAdenosine receptor A1Homo sapiens (human)
lipid catabolic processAdenosine receptor A1Homo sapiens (human)
negative regulation of synaptic transmission, GABAergicAdenosine receptor A1Homo sapiens (human)
positive regulation of nucleoside transportAdenosine receptor A1Homo sapiens (human)
negative regulation of neurotrophin productionAdenosine receptor A1Homo sapiens (human)
positive regulation of protein dephosphorylationAdenosine receptor A1Homo sapiens (human)
vasodilationAdenosine receptor A1Homo sapiens (human)
negative regulation of circadian sleep/wake cycle, non-REM sleepAdenosine receptor A1Homo sapiens (human)
negative regulation of apoptotic processAdenosine receptor A1Homo sapiens (human)
positive regulation of potassium ion transportAdenosine receptor A1Homo sapiens (human)
positive regulation of MAPK cascadeAdenosine receptor A1Homo sapiens (human)
negative regulation of hormone secretionAdenosine receptor A1Homo sapiens (human)
cognitionAdenosine receptor A1Homo sapiens (human)
leukocyte migrationAdenosine receptor A1Homo sapiens (human)
detection of temperature stimulus involved in sensory perception of painAdenosine receptor A1Homo sapiens (human)
negative regulation of lipid catabolic processAdenosine receptor A1Homo sapiens (human)
positive regulation of lipid catabolic processAdenosine receptor A1Homo sapiens (human)
regulation of sensory perception of painAdenosine receptor A1Homo sapiens (human)
negative regulation of synaptic transmission, glutamatergicAdenosine receptor A1Homo sapiens (human)
fatty acid homeostasisAdenosine receptor A1Homo sapiens (human)
excitatory postsynaptic potentialAdenosine receptor A1Homo sapiens (human)
long-term synaptic depressionAdenosine receptor A1Homo sapiens (human)
mucus secretionAdenosine receptor A1Homo sapiens (human)
negative regulation of mucus secretionAdenosine receptor A1Homo sapiens (human)
triglyceride homeostasisAdenosine receptor A1Homo sapiens (human)
regulation of cardiac muscle cell contractionAdenosine receptor A1Homo sapiens (human)
apoptotic signaling pathwayAdenosine receptor A1Homo sapiens (human)
regulation of presynaptic cytosolic calcium ion concentrationAdenosine receptor A1Homo sapiens (human)
negative regulation of long-term synaptic potentiationAdenosine receptor A1Homo sapiens (human)
negative regulation of long-term synaptic depressionAdenosine receptor A1Homo sapiens (human)
G protein-coupled receptor signaling pathwayAdenosine receptor A1Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Molecular Functions (20)

Processvia Protein(s)Taxonomy
G protein-coupled serotonin receptor activity5-hydroxytryptamine receptor 1AHomo sapiens (human)
protein binding5-hydroxytryptamine receptor 1AHomo sapiens (human)
receptor-receptor interaction5-hydroxytryptamine receptor 1AHomo sapiens (human)
neurotransmitter receptor activity5-hydroxytryptamine receptor 1AHomo sapiens (human)
serotonin binding5-hydroxytryptamine receptor 1AHomo sapiens (human)
G protein-coupled adenosine receptor activityAdenosine receptor A3Homo sapiens (human)
G protein-coupled adenosine receptor activityAdenosine receptor A2aHomo sapiens (human)
protein bindingAdenosine receptor A2aHomo sapiens (human)
calmodulin bindingAdenosine receptor A2aHomo sapiens (human)
lipid bindingAdenosine receptor A2aHomo sapiens (human)
enzyme bindingAdenosine receptor A2aHomo sapiens (human)
type 5 metabotropic glutamate receptor bindingAdenosine receptor A2aHomo sapiens (human)
identical protein bindingAdenosine receptor A2aHomo sapiens (human)
protein-containing complex bindingAdenosine receptor A2aHomo sapiens (human)
alpha-actinin bindingAdenosine receptor A2aHomo sapiens (human)
G protein-coupled adenosine receptor activityAdenosine receptor A2bHomo sapiens (human)
protein bindingAdenosine receptor A2bHomo sapiens (human)
G protein-coupled receptor activityAdenosine receptor A2bHomo sapiens (human)
G protein-coupled receptor bindingAdenosine receptor A1Homo sapiens (human)
purine nucleoside bindingAdenosine receptor A1Homo sapiens (human)
protein bindingAdenosine receptor A1Homo sapiens (human)
heat shock protein bindingAdenosine receptor A1Homo sapiens (human)
G-protein beta/gamma-subunit complex bindingAdenosine receptor A1Homo sapiens (human)
heterotrimeric G-protein bindingAdenosine receptor A1Homo sapiens (human)
protein heterodimerization activityAdenosine receptor A1Homo sapiens (human)
G protein-coupled adenosine receptor activityAdenosine receptor A1Homo sapiens (human)
G protein-coupled adenosine receptor activityAdenosine receptor A2aRattus norvegicus (Norway rat)
[Information is prepared from geneontology information from the June-17-2024 release]

Ceullar Components (19)

Processvia Protein(s)Taxonomy
plasma membrane5-hydroxytryptamine receptor 1AHomo sapiens (human)
synapse5-hydroxytryptamine receptor 1AHomo sapiens (human)
plasma membrane5-hydroxytryptamine receptor 1AHomo sapiens (human)
dendrite5-hydroxytryptamine receptor 1AHomo sapiens (human)
plasma membraneAdenosine receptor A3Homo sapiens (human)
presynaptic membraneAdenosine receptor A3Homo sapiens (human)
Schaffer collateral - CA1 synapseAdenosine receptor A3Homo sapiens (human)
dendriteAdenosine receptor A3Homo sapiens (human)
plasma membraneAdenosine receptor A3Homo sapiens (human)
synapseAdenosine receptor A3Homo sapiens (human)
plasma membraneAdenosine receptor A2aHomo sapiens (human)
intermediate filamentAdenosine receptor A2aHomo sapiens (human)
plasma membraneAdenosine receptor A2aHomo sapiens (human)
membraneAdenosine receptor A2aHomo sapiens (human)
dendriteAdenosine receptor A2aHomo sapiens (human)
axolemmaAdenosine receptor A2aHomo sapiens (human)
asymmetric synapseAdenosine receptor A2aHomo sapiens (human)
presynaptic membraneAdenosine receptor A2aHomo sapiens (human)
neuronal cell bodyAdenosine receptor A2aHomo sapiens (human)
postsynaptic membraneAdenosine receptor A2aHomo sapiens (human)
presynaptic active zoneAdenosine receptor A2aHomo sapiens (human)
glutamatergic synapseAdenosine receptor A2aHomo sapiens (human)
plasma membraneAdenosine receptor A2bHomo sapiens (human)
Schaffer collateral - CA1 synapseAdenosine receptor A2bHomo sapiens (human)
presynapseAdenosine receptor A2bHomo sapiens (human)
glutamatergic synapseAdenosine receptor A2bHomo sapiens (human)
plasma membraneAdenosine receptor A2bHomo sapiens (human)
plasma membraneAdenosine receptor A1Homo sapiens (human)
plasma membraneAdenosine receptor A1Homo sapiens (human)
basolateral plasma membraneAdenosine receptor A1Homo sapiens (human)
axolemmaAdenosine receptor A1Homo sapiens (human)
asymmetric synapseAdenosine receptor A1Homo sapiens (human)
presynaptic membraneAdenosine receptor A1Homo sapiens (human)
neuronal cell bodyAdenosine receptor A1Homo sapiens (human)
terminal boutonAdenosine receptor A1Homo sapiens (human)
dendritic spineAdenosine receptor A1Homo sapiens (human)
calyx of HeldAdenosine receptor A1Homo sapiens (human)
postsynaptic membraneAdenosine receptor A1Homo sapiens (human)
presynaptic active zoneAdenosine receptor A1Homo sapiens (human)
synapseAdenosine receptor A1Homo sapiens (human)
dendriteAdenosine receptor A1Homo sapiens (human)
Golgi membraneAdenosine receptor A2aRattus norvegicus (Norway rat)
[Information is prepared from geneontology information from the June-17-2024 release]

Bioassays (165)

Assay IDTitleYearJournalArticle
AID1571899Displacement of [125I]N6-(4-amino-3-iodobenzyl)adenosine-5-N-methyluronamide from mouse A3A adenosine receptor expressed in CHO cell membranes after 60 mins by scintillation proximity assay2019Journal of medicinal chemistry, 02-14, Volume: 62, Issue:3
Design and in Vivo Characterization of A
AID33427Affinity for the adenosine A2 receptor was evaluated in a competition assay in rat striatum using [3H]-CGS- 21680 as radioligand1994Journal of medicinal chemistry, May-27, Volume: 37, Issue:11
2-Alkynyl derivatives of adenosine-5'-N-ethyluronamide: selective A2 adenosine receptor agonists with potent inhibitory activity on platelet aggregation.
AID25036Hydrophobicity index (k'') (RP-HPLC pH 7.5)1995Journal of medicinal chemistry, Apr-28, Volume: 38, Issue:9
2-Aralkynyl and 2-heteroalkynyl derivatives of adenosine-5'-N-ethyluronamide as selective A2a adenosine receptor agonists.
AID155643Percentage of apoptotic cells in human peripheral blood mononuclear cells after 72 hour incubation at the concentration 1 uM1998Bioorganic & medicinal chemistry letters, Sep-22, Volume: 8, Issue:18
Modulation of apoptosis in human lymphocytes by adenosine analogues.
AID33901Inhibition of [3H]- NECA binding to adenosine receptor A21991Journal of medicinal chemistry, Dec, Volume: 34, Issue:12
Activity of N6-substituted 2-chloroadenosines at A1 and A2 adenosine receptors.
AID313265Displacement of [3H]NECA from human recombinant adenosine A3 receptor expressed in CHO cells2008Bioorganic & medicinal chemistry, Jan-01, Volume: 16, Issue:1
5'-Carbamoyl derivatives of 2'-C-methyl-purine nucleosides as selective A1 adenosine receptor agonists: affinity, efficacy, and selectivity for A1 receptor from different species.
AID340156Antitumor activity against human MCF7 cells after 48 hrs by MTS assay2008Journal of medicinal chemistry, Jul-24, Volume: 51, Issue:14
Ribose-modified purine nucleosides as ribonucleotide reductase inhibitors. Synthesis, antitumor activity, and molecular modeling of N6-substituted 3'-C-methyladenosine derivatives.
AID363482Binding affinity to human adenosine A1 receptor expressed in CHO cells2008Journal of medicinal chemistry, Sep-25, Volume: 51, Issue:18
Synthesis and biological evaluation of 2-amino-3-(4-chlorobenzoyl)-4-[N-(substituted) piperazin-1-yl]thiophenes as potent allosteric enhancers of the A1 adenosine receptor.
AID155645Percentage of apoptotic cells in human peripheral blood mononuclear cells after 72 hour incubation at the concentration 30 uM1998Bioorganic & medicinal chemistry letters, Sep-22, Volume: 8, Issue:18
Modulation of apoptosis in human lymphocytes by adenosine analogues.
AID224979Stimulation of [35S]GTP-gamma-S, binding to rat brain membranes by adenosine A1 receptor activation2000Journal of medicinal chemistry, Jan-27, Volume: 43, Issue:2
N-cycloalkyl derivatives of adenosine and 1-deazaadenosine as agonists and partial agonists of the A(1) adenosine receptor.
AID33769Functional activity against adenosine A2a receptor from rat aorta.1995Journal of medicinal chemistry, Apr-28, Volume: 38, Issue:9
2-Aralkynyl and 2-heteroalkynyl derivatives of adenosine-5'-N-ethyluronamide as selective A2a adenosine receptor agonists.
AID234752Selectivity as the ratio of Ki value towards A1 receptor to that of A2a receptor.1995Journal of medicinal chemistry, Apr-28, Volume: 38, Issue:9
2-Aralkynyl and 2-heteroalkynyl derivatives of adenosine-5'-N-ethyluronamide as selective A2a adenosine receptor agonists.
AID313266Agonist activity at human recombinant adenosine A2B receptor expressed in CHO cells assessed as activation of adenylyl cyclase activity2008Bioorganic & medicinal chemistry, Jan-01, Volume: 16, Issue:1
5'-Carbamoyl derivatives of 2'-C-methyl-purine nucleosides as selective A1 adenosine receptor agonists: affinity, efficacy, and selectivity for A1 receptor from different species.
AID1571891Displacement of [3H]N6-R-phenylisopropyladenosine from human A1A adenosine receptor expressed in CHO cell membranes after 60 mins by scintillation proximity assay2019Journal of medicinal chemistry, 02-14, Volume: 62, Issue:3
Design and in Vivo Characterization of A
AID340154Antitumor activity against human CaCo2 cells after 48 hrs by MTS assay2008Journal of medicinal chemistry, Jul-24, Volume: 51, Issue:14
Ribose-modified purine nucleosides as ribonucleotide reductase inhibitors. Synthesis, antitumor activity, and molecular modeling of N6-substituted 3'-C-methyladenosine derivatives.
AID30817Negative chronotropic activity via A2 Adenosine receptor was tested monitoring vasodilation in rat aorta1994Journal of medicinal chemistry, May-27, Volume: 37, Issue:11
2-Alkynyl derivatives of adenosine-5'-N-ethyluronamide: selective A2 adenosine receptor agonists with potent inhibitory activity on platelet aggregation.
AID313256Displacement of [3H]CCPA from adenosine A1 receptor in pig cortical membrane2008Bioorganic & medicinal chemistry, Jan-01, Volume: 16, Issue:1
5'-Carbamoyl derivatives of 2'-C-methyl-purine nucleosides as selective A1 adenosine receptor agonists: affinity, efficacy, and selectivity for A1 receptor from different species.
AID702168Anticonvulsant activity in CF-1 albino mouse assessed as protection against maximal electroshock-induced seizures at 2 mg/kg, ip by MES test2012Journal of medicinal chemistry, Sep-27, Volume: 55, Issue:18
Structural sweet spot for A1 adenosine receptor activation by truncated (N)-methanocarba nucleosides: receptor docking and potent anticonvulsant activity.
AID1281007Agonist activity at human Adenosine A3 receptor transfected in CHO-K1 cells assessed as inhibition of forskolin-stimulated cAMP production after 30 mins by multimode microplate reader analysis relative to total forskolin2016Journal of medicinal chemistry, Feb-11, Volume: 59, Issue:3
Discovery of Novel Adenosine Receptor Agonists That Exhibit Subtype Selectivity.
AID33939Tested for the binding affinity of A2a receptor by displacing the [3H]-CGS- 21680 in rat striatal membranes1994Journal of medicinal chemistry, Oct-14, Volume: 37, Issue:21
2-Substitution of N6-benzyladenosine-5'-uronamides enhances selectivity for A3 adenosine receptors.
AID32513Tested for the binding affinity of A1 receptor by displacing the [3H]-PIA in rat brain membranes1994Journal of medicinal chemistry, Oct-14, Volume: 37, Issue:21
2-Substitution of N6-benzyladenosine-5'-uronamides enhances selectivity for A3 adenosine receptors.
AID1281000Binding affinity to human Adenosine A2A receptor expressed in yeast cells coexpressed with chimeric GPA1/Galphas relative to NECA2016Journal of medicinal chemistry, Feb-11, Volume: 59, Issue:3
Discovery of Novel Adenosine Receptor Agonists That Exhibit Subtype Selectivity.
AID31859Binding affinity against adenosine A1 receptor from rat brain using [3H]CHA as a radioligand.1995Journal of medicinal chemistry, Apr-28, Volume: 38, Issue:9
2-Aralkynyl and 2-heteroalkynyl derivatives of adenosine-5'-N-ethyluronamide as selective A2a adenosine receptor agonists.
AID34248Displacement of [3H]NECA from human adenosine A2A receptor in stably transfected CHO cells2004Bioorganic & medicinal chemistry letters, Mar-22, Volume: 14, Issue:6
2-(N-acyl) and 2-N-acyl-N(6)-substituted analogues of adenosine and their affinity at the human adenosine receptors.
AID702166Anticonvulsant activity in CF-1 albino mouse assessed as protection against subcutaneous metrazol-induced seizures at 1 mg/kg, ip2012Journal of medicinal chemistry, Sep-27, Volume: 55, Issue:18
Structural sweet spot for A1 adenosine receptor activation by truncated (N)-methanocarba nucleosides: receptor docking and potent anticonvulsant activity.
AID33928Inhibitory activity at Adenosine A2A receptor by inhibition of [3H]-CGS- 21680 binding to bovine striatal membranes.1998Journal of medicinal chemistry, May-07, Volume: 41, Issue:10
2'-C-Methyl analogues of selective adenosine receptor agonists: synthesis and binding studies.
AID233405Ratio between Ki values of A1 and A2 receptors was determined1994Journal of medicinal chemistry, May-27, Volume: 37, Issue:11
2-Alkynyl derivatives of adenosine-5'-N-ethyluronamide: selective A2 adenosine receptor agonists with potent inhibitory activity on platelet aggregation.
AID32358Displacement of [3H]R-PIA from rat brain membrane Adenosine A1 receptor2000Journal of medicinal chemistry, Jun-01, Volume: 43, Issue:11
Methanocarba analogues of purine nucleosides as potent and selective adenosine receptor agonists.
AID31855Affinity towards adenosine A1 receptor from rat cortical membranes using [3H]DPCPX2001Journal of medicinal chemistry, Aug-30, Volume: 44, Issue:18
5'-O-alkyl ethers of N,2-substituted adenosine derivatives: partial agonists for the adenosine A1 and A3 receptors.
AID33507Binding affinity towards human Adenosine A3 receptor wild type2002Journal of medicinal chemistry, Sep-26, Volume: 45, Issue:20
Structural determinants of A(3) adenosine receptor activation: nucleoside ligands at the agonist/antagonist boundary.
AID1200770Agonist activity at human recombinant adenosine A1 receptor transfected in CHO cells assessed as inhibition of forskolin-induced adenylyl cyclase activity2015Journal of medicinal chemistry, Mar-12, Volume: 58, Issue:5
5'-C-Ethyl-tetrazolyl-N(6)-substituted adenosine and 2-chloro-adenosine derivatives as highly potent dual acting A1 adenosine receptor agonists and A3 adenosine receptor antagonists.
AID256765Maximal agonist effect at human adenosine A3 receptor in CHO cells at 10 uM by the inhibition of forskolin-stimulated cAMP production2005Journal of medicinal chemistry, Dec-29, Volume: 48, Issue:26
Semi-rational design of (north)-methanocarba nucleosides as dual acting A(1) and A(3) adenosine receptor agonists: novel prototypes for cardioprotection.
AID32012Binding affinity for adenosine A1 receptor was assayed by displacement of [3H]DPCPX from rat cortical membranes.2000Journal of medicinal chemistry, Jan-27, Volume: 43, Issue:2
N-cycloalkyl derivatives of adenosine and 1-deazaadenosine as agonists and partial agonists of the A(1) adenosine receptor.
AID33482Inhibitory activity against Adenosine A3 receptor by inhibiting specific [3H](R)-PIA binding to rat testis membranes1998Journal of medicinal chemistry, May-07, Volume: 41, Issue:10
2'-C-Methyl analogues of selective adenosine receptor agonists: synthesis and binding studies.
AID34574Affinity for human Adenosine A3 receptor expressed in CHO cell2002Journal of medicinal chemistry, Sep-26, Volume: 45, Issue:20
Structural determinants of A(3) adenosine receptor activation: nucleoside ligands at the agonist/antagonist boundary.
AID33485Tested for the binding affinity of A3 receptor by displacing N6-[[125I]-4-amino-3-iodobenzyl]-adenosine-5''-N-methyluronamide from membranes of CHO cells transfected with rat A3-cDNA1994Journal of medicinal chemistry, Oct-14, Volume: 37, Issue:21
2-Substitution of N6-benzyladenosine-5'-uronamides enhances selectivity for A3 adenosine receptors.
AID31721Affinity for adenosine A1 receptor assayed in a competition assay in rat brain using [3H]-CHA as radioligand1994Journal of medicinal chemistry, May-27, Volume: 37, Issue:11
2-Alkynyl derivatives of adenosine-5'-N-ethyluronamide: selective A2 adenosine receptor agonists with potent inhibitory activity on platelet aggregation.
AID1280985Agonist activity at human Adenosine A1 receptor expressed in yeast cells coexpressed with chimeric GPA1/Galphai1 after 16 hrs by beta galactosidase reporter gene assay2016Journal of medicinal chemistry, Feb-11, Volume: 59, Issue:3
Discovery of Novel Adenosine Receptor Agonists That Exhibit Subtype Selectivity.
AID1703318Displacement of [3H]-CCPA from human A1 receptor stably expressed in CHO cell membranes by radioligand competitive binding assay2020European journal of medicinal chemistry, Sep-01, Volume: 201Discovery of first-in-class multi-target adenosine A
AID34717Binding affinity towards Adenosine A3 receptor (H95A mutant receptor)2002Journal of medicinal chemistry, Sep-26, Volume: 45, Issue:20
Structural determinants of A(3) adenosine receptor activation: nucleoside ligands at the agonist/antagonist boundary.
AID30461Displacement of [3H]CCPA from human adenosine A1 receptor expressed in CHO cells2004Bioorganic & medicinal chemistry letters, Mar-22, Volume: 14, Issue:6
2-(N-acyl) and 2-N-acyl-N(6)-substituted analogues of adenosine and their affinity at the human adenosine receptors.
AID256760Displacement of [3H]R-PIA or [3H]CGS 21680 from human adenosine A1 receptor in CHO cells2005Journal of medicinal chemistry, Dec-29, Volume: 48, Issue:26
Semi-rational design of (north)-methanocarba nucleosides as dual acting A(1) and A(3) adenosine receptor agonists: novel prototypes for cardioprotection.
AID703961Displacement of [3H]DPCPX from human adenosine A1 receptor expressed in CHO cells after 90 mins2012Journal of medicinal chemistry, Sep-13, Volume: 55, Issue:17
Synthesis and biological evaluation of 2-amino-3-(4-chlorobenzoyl)-4-[(4-arylpiperazin-1-yl)methyl]-5-substituted-thiophenes. effect of the 5-modification on allosteric enhancer activity at the A1 adenosine receptor.
AID1571947Toxicity in Sprague-Dawley rat assessed as increase in blood pressure at 0.02 mg/kg, iv2019Journal of medicinal chemistry, 02-14, Volume: 62, Issue:3
Design and in Vivo Characterization of A
AID1571897Displacement of [3H]2-[p-(2-carboxyethyl)phenylethylamino]-5-N-ethylcarboxamidoadenosine from mouse A2A adenosine receptor expressed in HEK293 cell membranes after 60 mins by scintillation proximity assay2019Journal of medicinal chemistry, 02-14, Volume: 62, Issue:3
Design and in Vivo Characterization of A
AID231299Relative binding affinity for Adenosine A1 and A3 receptors2000Journal of medicinal chemistry, Jun-01, Volume: 43, Issue:11
Methanocarba analogues of purine nucleosides as potent and selective adenosine receptor agonists.
AID759401Agonist activity at mouse adenosine A1 receptor expressed in HEK293 cell membranes assessed as inhibition of forskolin-stimulated cAMP production preincubated for 30 mins prior to forskolin-treatment measured after 15 mins by ELISA2013Journal of medicinal chemistry, Jul-25, Volume: 56, Issue:14
Rational design of sulfonated A3 adenosine receptor-selective nucleosides as pharmacological tools to study chronic neuropathic pain.
AID1280990Agonist activity at human Adenosine A2B receptor expressed in yeast cells coexpressed with chimeric GPA1/Galphas after 16 hrs by beta-galactosidase reporter gene assay relative to NECA2016Journal of medicinal chemistry, Feb-11, Volume: 59, Issue:3
Discovery of Novel Adenosine Receptor Agonists That Exhibit Subtype Selectivity.
AID256764Binding affinity to rat adenosine A3 receptor in CHO cells2005Journal of medicinal chemistry, Dec-29, Volume: 48, Issue:26
Semi-rational design of (north)-methanocarba nucleosides as dual acting A(1) and A(3) adenosine receptor agonists: novel prototypes for cardioprotection.
AID45252Potency NECA-induced signal mediated by human A2B receptor in CHO cells at 100 uM2004Bioorganic & medicinal chemistry letters, Mar-22, Volume: 14, Issue:6
2-(N-acyl) and 2-N-acyl-N(6)-substituted analogues of adenosine and their affinity at the human adenosine receptors.
AID30905In vitro binding affinity towards human adenosine A1 receptor by [3H]DPCPX displacement.2003Journal of medicinal chemistry, Apr-10, Volume: 46, Issue:8
N6-cyclopentyl-2-(3-phenylaminocarbonyltriazene-1-yl)adenosine (TCPA), a very selective agonist with high affinity for the human adenosine A1 receptor.
AID1280987Agonist activity at human Adenosine A2B receptor expressed in yeast cells coexpressed with chimeric GPA1/Galphas after 16 hrs by beta-galactosidase reporter gene assay2016Journal of medicinal chemistry, Feb-11, Volume: 59, Issue:3
Discovery of Novel Adenosine Receptor Agonists That Exhibit Subtype Selectivity.
AID698900Selectivity ratio of Ki for human A2BR to Ki for human A1AR2012Journal of medicinal chemistry, Jul-26, Volume: 55, Issue:14
Orally active adenosine A(1) receptor agonists with antinociceptive effects in mice.
AID699043Agonist activity at human A1AR expressed in HEK293T/17 cells assessed as inhibition of forskolin-induced cAMP accumulation incubated for 10 mins by luciferase reporter assay2012Journal of medicinal chemistry, Jul-26, Volume: 55, Issue:14
Orally active adenosine A(1) receptor agonists with antinociceptive effects in mice.
AID1257224Inhibition of Trichomonas vaginalis adenosine-guanosine preferring ribohydrolase after 40 mins2015Bioorganic & medicinal chemistry letters, Nov-15, Volume: 25, Issue:22
Adenosine/guanosine preferring nucleoside ribohydrolase is a distinct, druggable antitrichomonal target.
AID189321Percent relative intrinsic activity compared to CCPA2000Journal of medicinal chemistry, Jan-27, Volume: 43, Issue:2
N-cycloalkyl derivatives of adenosine and 1-deazaadenosine as agonists and partial agonists of the A(1) adenosine receptor.
AID313269Selectivity for human adenosine A3 receptor over human adenosine A2A receptor2008Bioorganic & medicinal chemistry, Jan-01, Volume: 16, Issue:1
5'-Carbamoyl derivatives of 2'-C-methyl-purine nucleosides as selective A1 adenosine receptor agonists: affinity, efficacy, and selectivity for A1 receptor from different species.
AID32002Inhibitory activity at Adenosine A1 receptor by inhibition of [3H]CHA binding to bovine brain cortical membranes.1998Journal of medicinal chemistry, May-07, Volume: 41, Issue:10
2'-C-Methyl analogues of selective adenosine receptor agonists: synthesis and binding studies.
AID1451003Induction of adipogenesis in mouse 7F2 cells transfected with human AR assessed as increase in the production of adiponectin at 1 to 10 uM after 7 to 12 days by staining based oil red O phase contrast microscopic method relative to control2017Journal of medicinal chemistry, 09-14, Volume: 60, Issue:17
Polypharmacology of N
AID233832Relative affinities for rat adenosine A1 and A2a receptors1995Journal of medicinal chemistry, Sep-01, Volume: 38, Issue:18
2-[N'-(3-arylallylidene)hydrazino]adenosines showing A2a adenosine agonist properties and vasodilation activity.
AID235530Selectivity for adenosine A1 and A2A receptors2003Journal of medicinal chemistry, Apr-10, Volume: 46, Issue:8
N6-cyclopentyl-2-(3-phenylaminocarbonyltriazene-1-yl)adenosine (TCPA), a very selective agonist with high affinity for the human adenosine A1 receptor.
AID1703320Displacement of [3H]-HEMADO from human A3 receptor stably expressed in CHO cell membranes by radioligand competitive binding assay2020European journal of medicinal chemistry, Sep-01, Volume: 201Discovery of first-in-class multi-target adenosine A
AID32772Inhibition of [125 I]-IABMECA binding to human adenosine A3 receptor2003Journal of medicinal chemistry, Apr-10, Volume: 46, Issue:8
N6-cyclopentyl-2-(3-phenylaminocarbonyltriazene-1-yl)adenosine (TCPA), a very selective agonist with high affinity for the human adenosine A1 receptor.
AID34844In vitro inhibition of human neutrophil activation via Adenosine A2A receptor.2000Bioorganic & medicinal chemistry letters, Feb-21, Volume: 10, Issue:4
The discovery and synthesis of highly potent, A2a receptor agonists.
AID1280989Agonist activity at human Adenosine A2A receptor expressed in yeast cells coexpressed with chimeric GPA1/Galphas after 16 hrs by beta-galactosidase reporter gene assay relative to NECA2016Journal of medicinal chemistry, Feb-11, Volume: 59, Issue:3
Discovery of Novel Adenosine Receptor Agonists That Exhibit Subtype Selectivity.
AID1281006Agonist activity at human Adenosine A1 receptor transfected in CHO-K1 cells assessed as inhibition of forskolin-stimulated cAMP production after 30 mins by multimode microplate reader analysis relative to total forskolin2016Journal of medicinal chemistry, Feb-11, Volume: 59, Issue:3
Discovery of Novel Adenosine Receptor Agonists That Exhibit Subtype Selectivity.
AID32863Binding affinity for adenosine A2A receptor was determined by displacement of [3H]-DPCPX from rat striatal membranes.2000Journal of medicinal chemistry, Jan-27, Volume: 43, Issue:2
N-cycloalkyl derivatives of adenosine and 1-deazaadenosine as agonists and partial agonists of the A(1) adenosine receptor.
AID699044Agonist activity at human A1AR expressed in HEK293T/17 cells assessed as inhibition of isoproterenol-induced cAMP accumulation incubated for 10 mins by luciferase reporter assay2012Journal of medicinal chemistry, Jul-26, Volume: 55, Issue:14
Orally active adenosine A(1) receptor agonists with antinociceptive effects in mice.
AID233378Inhibitory selectivity at Adenosine A3 receptor compared to Adenosine 1 receptor.1998Journal of medicinal chemistry, May-07, Volume: 41, Issue:10
2'-C-Methyl analogues of selective adenosine receptor agonists: synthesis and binding studies.
AID32634Displacement of [3H]CHA from Adenosine A1 receptor of rat brain1995Journal of medicinal chemistry, Sep-01, Volume: 38, Issue:18
2-[N'-(3-arylallylidene)hydrazino]adenosines showing A2a adenosine agonist properties and vasodilation activity.
AID702171Anticonvulsant activity in ip dosed CF-1 albino mouse assessed as protection against 6 Hz psychomotor seizure after 1 hr by minimal clonic seizure test2012Journal of medicinal chemistry, Sep-27, Volume: 55, Issue:18
Structural sweet spot for A1 adenosine receptor activation by truncated (N)-methanocarba nucleosides: receptor docking and potent anticonvulsant activity.
AID31265Functional activity against adenosine A1 receptor from rat atria.1995Journal of medicinal chemistry, Apr-28, Volume: 38, Issue:9
2-Aralkynyl and 2-heteroalkynyl derivatives of adenosine-5'-N-ethyluronamide as selective A2a adenosine receptor agonists.
AID1571898Displacement of [125I]N6-(4-amino-3-iodobenzyl)adenosine-5-N-methyluronamide from human A3A adenosine receptor expressed in CHO cell membranes after 60 mins by scintillation proximity assay2019Journal of medicinal chemistry, 02-14, Volume: 62, Issue:3
Design and in Vivo Characterization of A
AID1280999Binding affinity to human Adenosine A1 receptor expressed in yeast cells coexpressed with chimeric GPA1/Galphai1 relative to NECA2016Journal of medicinal chemistry, Feb-11, Volume: 59, Issue:3
Discovery of Novel Adenosine Receptor Agonists That Exhibit Subtype Selectivity.
AID231317Ratio of binding affinity for adenosine A2A receptor to adenosine A1 receptor2004Bioorganic & medicinal chemistry letters, Mar-22, Volume: 14, Issue:6
2-(N-acyl) and 2-N-acyl-N(6)-substituted analogues of adenosine and their affinity at the human adenosine receptors.
AID702172Toxicity in ip dosed CF-1 albino mouse assessed as behavioral changes after 1 hr by rotarod test2012Journal of medicinal chemistry, Sep-27, Volume: 55, Issue:18
Structural sweet spot for A1 adenosine receptor activation by truncated (N)-methanocarba nucleosides: receptor docking and potent anticonvulsant activity.
AID33752Ratio of A2 to A1.1992Journal of medicinal chemistry, Feb-07, Volume: 35, Issue:3
Adenosine receptors: pharmacology, structure-activity relationships, and therapeutic potential.
AID1282224Binding affinity to Adenosine receptor A3 (unknown origin)2016Journal of medicinal chemistry, Feb-11, Volume: 59, Issue:3
Tactical Approaches to Interconverting GPCR Agonists and Antagonists.
AID256761Displacement of [3H]R-PIA or [3H]CGS 21680 from human adenosine A2A receptor in CHO cells2005Journal of medicinal chemistry, Dec-29, Volume: 48, Issue:26
Semi-rational design of (north)-methanocarba nucleosides as dual acting A(1) and A(3) adenosine receptor agonists: novel prototypes for cardioprotection.
AID33060Relative potency for human adenosine A3 receptor (Ki value)2003Journal of medicinal chemistry, Apr-10, Volume: 46, Issue:8
N6-cyclopentyl-2-(3-phenylaminocarbonyltriazene-1-yl)adenosine (TCPA), a very selective agonist with high affinity for the human adenosine A1 receptor.
AID340155Antitumor activity against human HT29 cells after 48 hrs by MTS assay2008Journal of medicinal chemistry, Jul-24, Volume: 51, Issue:14
Ribose-modified purine nucleosides as ribonucleotide reductase inhibitors. Synthesis, antitumor activity, and molecular modeling of N6-substituted 3'-C-methyladenosine derivatives.
AID32295Ex vivo inhibition of guinea pig ileum twitch via Adenosine A1 receptor.2000Bioorganic & medicinal chemistry letters, Feb-21, Volume: 10, Issue:4
The discovery and synthesis of highly potent, A2a receptor agonists.
AID313255Displacement of [3H]CCPA from adenosine A1 receptor in bovine cortical membrane2008Bioorganic & medicinal chemistry, Jan-01, Volume: 16, Issue:1
5'-Carbamoyl derivatives of 2'-C-methyl-purine nucleosides as selective A1 adenosine receptor agonists: affinity, efficacy, and selectivity for A1 receptor from different species.
AID1281005Agonist activity at human Adenosine A3 receptor transfected in CHO-K1 cells assessed as inhibition of forskolin-stimulated cAMP production after 30 mins by multimode microplate reader analysis2016Journal of medicinal chemistry, Feb-11, Volume: 59, Issue:3
Discovery of Novel Adenosine Receptor Agonists That Exhibit Subtype Selectivity.
AID33746Binding affinity against adenosine A2 receptor using [3H]- NECA as radioligand1992Journal of medicinal chemistry, Feb-07, Volume: 35, Issue:3
Adenosine receptors: pharmacology, structure-activity relationships, and therapeutic potential.
AID313264Displacement of [3H]NECA from human recombinant adenosine A2A receptor expressed in CHO cells2008Bioorganic & medicinal chemistry, Jan-01, Volume: 16, Issue:1
5'-Carbamoyl derivatives of 2'-C-methyl-purine nucleosides as selective A1 adenosine receptor agonists: affinity, efficacy, and selectivity for A1 receptor from different species.
AID34733Bnding affinity in membrane of CHO cell stably expressing recombinant human Adenosine A3 receptor using [3H]8-ethyl-4-methyl-2-phenyl-(8R)-4,5,7,8-tetrahydro-1H-imidazo[2,1-i]-purin-5-one as radioligand2002Journal of medicinal chemistry, Sep-26, Volume: 45, Issue:20
Structural determinants of A(3) adenosine receptor activation: nucleoside ligands at the agonist/antagonist boundary.
AID34272Percent efficacy against human Adenosine A3 receptor expressed in CHO cell2002Journal of medicinal chemistry, Sep-26, Volume: 45, Issue:20
Structural determinants of A(3) adenosine receptor activation: nucleoside ligands at the agonist/antagonist boundary.
AID313257Displacement of [3H]CGS21680 from adenosine A1 receptor in bovine striatum membrane2008Bioorganic & medicinal chemistry, Jan-01, Volume: 16, Issue:1
5'-Carbamoyl derivatives of 2'-C-methyl-purine nucleosides as selective A1 adenosine receptor agonists: affinity, efficacy, and selectivity for A1 receptor from different species.
AID1280997Binding affinity to human Adenosine A2A receptor expressed in yeast cells coexpressed with GPA1/Galphas2016Journal of medicinal chemistry, Feb-11, Volume: 59, Issue:3
Discovery of Novel Adenosine Receptor Agonists That Exhibit Subtype Selectivity.
AID155644Percentage of apoptotic cells in human peripheral blood mononuclear cells after 72 hour incubation at the concentration 10 uM1998Bioorganic & medicinal chemistry letters, Sep-22, Volume: 8, Issue:18
Modulation of apoptosis in human lymphocytes by adenosine analogues.
AID1281004Agonist activity at human Adenosine A1 receptor transfected in CHO-K1 cells assessed as inhibition of forskolin-stimulated cAMP production after 30 mins by multimode microplate reader analysis2016Journal of medicinal chemistry, Feb-11, Volume: 59, Issue:3
Discovery of Novel Adenosine Receptor Agonists That Exhibit Subtype Selectivity.
AID231406Inhibition compared to inhibition by NECA (IC50 ratio) of rabbit platelet aggregation induced by ADP1994Journal of medicinal chemistry, May-27, Volume: 37, Issue:11
2-Alkynyl derivatives of adenosine-5'-N-ethyluronamide: selective A2 adenosine receptor agonists with potent inhibitory activity on platelet aggregation.
AID233379Inhibitory selectivity at Adenosine A3 receptor compared to Adenosine 2A receptor.1998Journal of medicinal chemistry, May-07, Volume: 41, Issue:10
2'-C-Methyl analogues of selective adenosine receptor agonists: synthesis and binding studies.
AID34681Tested for binding affinity towards human adenosine A2A receptor using [3H]ZM-241385 as radioligand2003Journal of medicinal chemistry, Apr-10, Volume: 46, Issue:8
N6-cyclopentyl-2-(3-phenylaminocarbonyltriazene-1-yl)adenosine (TCPA), a very selective agonist with high affinity for the human adenosine A1 receptor.
AID702176Activity at human A1 adenosine receptor expressed in CHO cells assessed as inhibition of forskolin-stimulated cAMP production at 10 uM after 30 min2012Journal of medicinal chemistry, Sep-27, Volume: 55, Issue:18
Structural sweet spot for A1 adenosine receptor activation by truncated (N)-methanocarba nucleosides: receptor docking and potent anticonvulsant activity.
AID702169Anticonvulsant activity in CF-1 albino mouse assessed as protection against maximal electroshock-induced seizures at 1 mg/kg, ip by MES test2012Journal of medicinal chemistry, Sep-27, Volume: 55, Issue:18
Structural sweet spot for A1 adenosine receptor activation by truncated (N)-methanocarba nucleosides: receptor docking and potent anticonvulsant activity.
AID34706Binding affinity in membrane of CHO cell stably expressing recombinant human Adenosine A3 receptor in the presence of GTPgammaS using [3H]8-ethyl-4-methyl-2-phenyl-(8R)-4,5,7,8-tetrahydro-1H-imidazo[2,1-i]-purin-5-one as radioligand2002Journal of medicinal chemistry, Sep-26, Volume: 45, Issue:20
Structural determinants of A(3) adenosine receptor activation: nucleoside ligands at the agonist/antagonist boundary.
AID34855Affinity towards Adenosine A2A receptor from rat striatal membranes using [3H]-ZM 241385 radioligand2001Journal of medicinal chemistry, Aug-30, Volume: 44, Issue:18
5'-O-alkyl ethers of N,2-substituted adenosine derivatives: partial agonists for the adenosine A1 and A3 receptors.
AID1280998Binding affinity to human Adenosine A2B receptor expressed in yeast cells coexpressed with GPA1/Galphas2016Journal of medicinal chemistry, Feb-11, Volume: 59, Issue:3
Discovery of Novel Adenosine Receptor Agonists That Exhibit Subtype Selectivity.
AID1571896Displacement of [3H]2-[p-(2-carboxyethyl)phenylethylamino]-5-N-ethylcarboxamidoadenosine from human A2A adenosine receptor expressed in HEK293 cell membranes after 60 mins by scintillation proximity assay2019Journal of medicinal chemistry, 02-14, Volume: 62, Issue:3
Design and in Vivo Characterization of A
AID34573Affinity towards Adenosine A3 receptor expressed in HEK 293 cells using [125I]AB-MECA radioligand2001Journal of medicinal chemistry, Aug-30, Volume: 44, Issue:18
5'-O-alkyl ethers of N,2-substituted adenosine derivatives: partial agonists for the adenosine A1 and A3 receptors.
AID34735Displacement of [3H]NECA from human adenosine A3 receptor in stably transfected HEK cells2004Bioorganic & medicinal chemistry letters, Mar-22, Volume: 14, Issue:6
2-(N-acyl) and 2-N-acyl-N(6)-substituted analogues of adenosine and their affinity at the human adenosine receptors.
AID1185693Antagonist activity at human adenosine A1 receptor expressed in CHO cells assessed as inhibition of CCPA-stimulated cAMP level at 100 nM by scintillation counting analysis2014European journal of medicinal chemistry, Sep-12, Volume: 847-Amino-2-phenylpyrazolo[4,3-d]pyrimidine derivatives: structural investigations at the 5-position to target human A₁ and A(2A) adenosine receptors. Molecular modeling and pharmacological studies.
AID759400Agonist activity at mouse adenosine A1 receptor expressed in HEK293 cell membranes assessed as inhibition of forskolin-stimulated cAMP production preincubated for 30 mins prior to forskolin-treatment measured after 15 mins by ELISA relative to control2013Journal of medicinal chemistry, Jul-25, Volume: 56, Issue:14
Rational design of sulfonated A3 adenosine receptor-selective nucleosides as pharmacological tools to study chronic neuropathic pain.
AID1281001Binding affinity to human Adenosine A2B receptor expressed in yeast cells coexpressed with chimeric GPA1/Galphas relative to NECA2016Journal of medicinal chemistry, Feb-11, Volume: 59, Issue:3
Discovery of Novel Adenosine Receptor Agonists That Exhibit Subtype Selectivity.
AID1451004Induction of adipogenesis in human bone marrow-derived mesenchymal stem cells assessed as increase in adiponectin production at 20.4 uM after 7 days in presence of IDX2017Journal of medicinal chemistry, 09-14, Volume: 60, Issue:17
Polypharmacology of N
AID340153Antitumor activity against human K562 cells after 48 hrs by MTS assay2008Journal of medicinal chemistry, Jul-24, Volume: 51, Issue:14
Ribose-modified purine nucleosides as ribonucleotide reductase inhibitors. Synthesis, antitumor activity, and molecular modeling of N6-substituted 3'-C-methyladenosine derivatives.
AID702170Anticonvulsant activity in CF-1 albino mouse assessed as protection against maximal electroshock-induced seizures at 3 mg/kg, ip by MES test2012Journal of medicinal chemistry, Sep-27, Volume: 55, Issue:18
Structural sweet spot for A1 adenosine receptor activation by truncated (N)-methanocarba nucleosides: receptor docking and potent anticonvulsant activity.
AID31261Activity at Adenosine A1 receptor of rat atria1995Journal of medicinal chemistry, Sep-01, Volume: 38, Issue:18
2-[N'-(3-arylallylidene)hydrazino]adenosines showing A2a adenosine agonist properties and vasodilation activity.
AID1162471Displacement of [3H]DPCPX from human adenosine A1 receptor expressed in CHO cell membranes2014Journal of medicinal chemistry, Sep-25, Volume: 57, Issue:18
Synthesis and biological evaluation of novel allosteric enhancers of the A1 adenosine receptor based on 2-amino-3-(4'-chlorobenzoyl)-4-substituted-5-arylethynyl thiophene.
AID33295Displacement of [3H]- ZM-241385 from human adenosine A2B receptor expressed in HEK cells2000Journal of medicinal chemistry, Jun-01, Volume: 43, Issue:11
Methanocarba analogues of purine nucleosides as potent and selective adenosine receptor agonists.
AID699040Selectivity ratio of Ki for human A2AR to Ki for human A1AR2012Journal of medicinal chemistry, Jul-26, Volume: 55, Issue:14
Orally active adenosine A(1) receptor agonists with antinociceptive effects in mice.
AID155782Percentage of apoptotic cells in human peripheral blood mononuclear cells after 72 hour incubation at the concentration 60 uM1998Bioorganic & medicinal chemistry letters, Sep-22, Volume: 8, Issue:18
Modulation of apoptosis in human lymphocytes by adenosine analogues.
AID25037Hydrophobicity index (k') (RP-HPLC)1994Journal of medicinal chemistry, May-27, Volume: 37, Issue:11
2-Alkynyl derivatives of adenosine-5'-N-ethyluronamide: selective A2 adenosine receptor agonists with potent inhibitory activity on platelet aggregation.
AID1571972Agonist activity at rat A1A adenosine receptor expressed in CHO-K1 cell membranes at 10 uM incubated for 60 mins by [35S]GTPgammaS binding assay relative to (2S,3S,4R,5R)-5-(6-amino-9H-purin-9-yl)-N-ethyl-3,4-dihydroxytetrahydrofuran-2-carboxamide2019Journal of medicinal chemistry, 02-14, Volume: 62, Issue:3
Design and in Vivo Characterization of A
AID1280986Agonist activity at human Adenosine A2A receptor expressed in yeast cells coexpressed with chimeric GPA1/Galphas after 16 hrs by beta-galactosidase reporter gene assay2016Journal of medicinal chemistry, Feb-11, Volume: 59, Issue:3
Discovery of Novel Adenosine Receptor Agonists That Exhibit Subtype Selectivity.
AID313268Selectivity for human adenosine A1 receptor over human adenosine A3 receptor2008Bioorganic & medicinal chemistry, Jan-01, Volume: 16, Issue:1
5'-Carbamoyl derivatives of 2'-C-methyl-purine nucleosides as selective A1 adenosine receptor agonists: affinity, efficacy, and selectivity for A1 receptor from different species.
AID33790Binding affinity against adenosine A2a receptor from rat striatum using [3H]-CGS- 21680 as a radioligand.1995Journal of medicinal chemistry, Apr-28, Volume: 38, Issue:9
2-Aralkynyl and 2-heteroalkynyl derivatives of adenosine-5'-N-ethyluronamide as selective A2a adenosine receptor agonists.
AID32177Binding affinity against adenosine A1 receptor using [3H]-CHA or [3H]PIA as radioligand1992Journal of medicinal chemistry, Feb-07, Volume: 35, Issue:3
Adenosine receptors: pharmacology, structure-activity relationships, and therapeutic potential.
AID233377Inhibitory selectivity at Adenosine 2A receptor compared to Adenosine 1 receptor.1998Journal of medicinal chemistry, May-07, Volume: 41, Issue:10
2'-C-Methyl analogues of selective adenosine receptor agonists: synthesis and binding studies.
AID34719Binding affinity towards Adenosine A3 receptor (W243 mutant receptor)2002Journal of medicinal chemistry, Sep-26, Volume: 45, Issue:20
Structural determinants of A(3) adenosine receptor activation: nucleoside ligands at the agonist/antagonist boundary.
AID1703319Displacement of [3H]-NECA from human A2A receptor stably expressed in CHO cell membranes by radioligand competitive binding assay2020European journal of medicinal chemistry, Sep-01, Volume: 201Discovery of first-in-class multi-target adenosine A
AID32896Displacement of specific [3H]-CGS- 21680 binding to adenosine A2A receptor in rat striatal membranes2000Journal of medicinal chemistry, Jun-01, Volume: 43, Issue:11
Methanocarba analogues of purine nucleosides as potent and selective adenosine receptor agonists.
AID229821Ratio of Ki for A1 and A3 receptors1994Journal of medicinal chemistry, Oct-14, Volume: 37, Issue:21
2-Substitution of N6-benzyladenosine-5'-uronamides enhances selectivity for A3 adenosine receptors.
AID703962Binding affinity to human adenosine A1 receptor expressed in CHO cells assessed per mg of protein after 90 mins2012Journal of medicinal chemistry, Sep-13, Volume: 55, Issue:17
Synthesis and biological evaluation of 2-amino-3-(4-chlorobenzoyl)-4-[(4-arylpiperazin-1-yl)methyl]-5-substituted-thiophenes. effect of the 5-modification on allosteric enhancer activity at the A1 adenosine receptor.
AID256762Binding affinity to human adenosine A3 receptor in CHO cells2005Journal of medicinal chemistry, Dec-29, Volume: 48, Issue:26
Semi-rational design of (north)-methanocarba nucleosides as dual acting A(1) and A(3) adenosine receptor agonists: novel prototypes for cardioprotection.
AID313267Selectivity for human adenosine A1 receptor over human adenosine A2A receptor2008Bioorganic & medicinal chemistry, Jan-01, Volume: 16, Issue:1
5'-Carbamoyl derivatives of 2'-C-methyl-purine nucleosides as selective A1 adenosine receptor agonists: affinity, efficacy, and selectivity for A1 receptor from different species.
AID1280996Binding affinity to human Adenosine A1 receptor expressed in yeast cells coexpressed with chimeric GPA1/Galphai12016Journal of medicinal chemistry, Feb-11, Volume: 59, Issue:3
Discovery of Novel Adenosine Receptor Agonists That Exhibit Subtype Selectivity.
AID231318Ratio of binding affinity for adenosine A3 receptor to adenosine A1 receptor2004Bioorganic & medicinal chemistry letters, Mar-22, Volume: 14, Issue:6
2-(N-acyl) and 2-N-acyl-N(6)-substituted analogues of adenosine and their affinity at the human adenosine receptors.
AID1280988Agonist activity at human Adenosine A1 receptor expressed in yeast cells coexpressed with chimeric GPA1/Galphai1 after 16 hrs by beta galactosidase reporter gene assay relative to NECA2016Journal of medicinal chemistry, Feb-11, Volume: 59, Issue:3
Discovery of Novel Adenosine Receptor Agonists That Exhibit Subtype Selectivity.
AID702167Anticonvulsant activity in CF-1 albino mouse assessed as protection against subcutaneous metrazol-induced seizures at 3 mg/kg, ip2012Journal of medicinal chemistry, Sep-27, Volume: 55, Issue:18
Structural sweet spot for A1 adenosine receptor activation by truncated (N)-methanocarba nucleosides: receptor docking and potent anticonvulsant activity.
AID33479Displacement of [125I]- AB-MECA from rat adenosine A3 receptor expressed in HEK cells2000Journal of medicinal chemistry, Jun-01, Volume: 43, Issue:11
Methanocarba analogues of purine nucleosides as potent and selective adenosine receptor agonists.
AID1257226Inhibition of Trichomonas vaginalis uridine ribohydrolase after 40 mins2015Bioorganic & medicinal chemistry letters, Nov-15, Volume: 25, Issue:22
Adenosine/guanosine preferring nucleoside ribohydrolase is a distinct, druggable antitrichomonal target.
AID33903Ratio of binding potencies at adenosine A2AR and AIAR receptors1991Journal of medicinal chemistry, Dec, Volume: 34, Issue:12
Activity of N6-substituted 2-chloroadenosines at A1 and A2 adenosine receptors.
AID31086Relative potency for human adenosine A1 receptor (Ki value)2003Journal of medicinal chemistry, Apr-10, Volume: 46, Issue:8
N6-cyclopentyl-2-(3-phenylaminocarbonyltriazene-1-yl)adenosine (TCPA), a very selective agonist with high affinity for the human adenosine A1 receptor.
AID34848Relative potency for human adenosine A2A receptor (Ki value)2003Journal of medicinal chemistry, Apr-10, Volume: 46, Issue:8
N6-cyclopentyl-2-(3-phenylaminocarbonyltriazene-1-yl)adenosine (TCPA), a very selective agonist with high affinity for the human adenosine A1 receptor.
AID230000Ratio of Ki for A2a and A3 receptors1994Journal of medicinal chemistry, Oct-14, Volume: 37, Issue:21
2-Substitution of N6-benzyladenosine-5'-uronamides enhances selectivity for A3 adenosine receptors.
AID235529Selectivity for adenosine A1 and A3 receptors2003Journal of medicinal chemistry, Apr-10, Volume: 46, Issue:8
N6-cyclopentyl-2-(3-phenylaminocarbonyltriazene-1-yl)adenosine (TCPA), a very selective agonist with high affinity for the human adenosine A1 receptor.
AID33948Selectivity ratio of Ki of the adenosine A2a receptor and Ki of adenosine A1 receptor2000Journal of medicinal chemistry, Jan-27, Volume: 43, Issue:2
N-cycloalkyl derivatives of adenosine and 1-deazaadenosine as agonists and partial agonists of the A(1) adenosine receptor.
AID32179Inhibition of [3H]- (R)-P1A binding to adenosine A1 receptor1991Journal of medicinal chemistry, Dec, Volume: 34, Issue:12
Activity of N6-substituted 2-chloroadenosines at A1 and A2 adenosine receptors.
AID33943Displacement of [3H]-CGS- 21680 from Adenosine A2A receptor of rat striatum1995Journal of medicinal chemistry, Sep-01, Volume: 38, Issue:18
2-[N'-(3-arylallylidene)hydrazino]adenosines showing A2a adenosine agonist properties and vasodilation activity.
AID313258Displacement of [3H]CGS21680 from adenosine A1 receptor in pig striatum membrane2008Bioorganic & medicinal chemistry, Jan-01, Volume: 16, Issue:1
5'-Carbamoyl derivatives of 2'-C-methyl-purine nucleosides as selective A1 adenosine receptor agonists: affinity, efficacy, and selectivity for A1 receptor from different species.
AID313263Displacement of [3H]CCPA from human recombinant adenosine A1 receptor expressed in CHO cells2008Bioorganic & medicinal chemistry, Jan-01, Volume: 16, Issue:1
5'-Carbamoyl derivatives of 2'-C-methyl-purine nucleosides as selective A1 adenosine receptor agonists: affinity, efficacy, and selectivity for A1 receptor from different species.
AID1571893Displacement of [3H]N6-R-phenylisopropyladenosine from mouse A1A adenosine receptor expressed in CHO cell membranes after 60 mins by scintillation proximity assay2019Journal of medicinal chemistry, 02-14, Volume: 62, Issue:3
Design and in Vivo Characterization of A
AID1571971Agonist activity at rat A1A adenosine receptor expressed in CHO-K1 cell membranes incubated for 60 mins by [35S]GTPgammaS binding assay2019Journal of medicinal chemistry, 02-14, Volume: 62, Issue:3
Design and in Vivo Characterization of A
AID33634Anti-aggregatory activity against adenosine A2A receptor from rabbit platelets. Potency ratio was reported with reference to the NECA IC50 of 0.2 uM.1995Journal of medicinal chemistry, Apr-28, Volume: 38, Issue:9
2-Aralkynyl and 2-heteroalkynyl derivatives of adenosine-5'-N-ethyluronamide as selective A2a adenosine receptor agonists.
AID31266Negative chronotropic activity via A1 Adenosine receptor was tested in spontaneously beating rat atria1994Journal of medicinal chemistry, May-27, Volume: 37, Issue:11
2-Alkynyl derivatives of adenosine-5'-N-ethyluronamide: selective A2 adenosine receptor agonists with potent inhibitory activity on platelet aggregation.
AID1257225Inhibition of Trichomonas vaginalis adenosine-guanosine preferring ribohydrolase after 40 mins in presence of 0.01% triton X-1002015Bioorganic & medicinal chemistry letters, Nov-15, Volume: 25, Issue:22
Adenosine/guanosine preferring nucleoside ribohydrolase is a distinct, druggable antitrichomonal target.
AID702179Displacement of [3H]CGS21680 from human A2a adenosine receptor expressed in HEK293 cells after 60 min by Perkin Elmer Liquid Scintillation Analyzer2012Journal of medicinal chemistry, Sep-27, Volume: 55, Issue:18
Structural sweet spot for A1 adenosine receptor activation by truncated (N)-methanocarba nucleosides: receptor docking and potent anticonvulsant activity.
AID30310Inhibition of cAMP formation in CHO cells expressing adenosine A1 receptor2003Journal of medicinal chemistry, Apr-10, Volume: 46, Issue:8
N6-cyclopentyl-2-(3-phenylaminocarbonyltriazene-1-yl)adenosine (TCPA), a very selective agonist with high affinity for the human adenosine A1 receptor.
AID32781Effective concentration against A2AR mediated P12 adenylatencyclase activity1991Journal of medicinal chemistry, Dec, Volume: 34, Issue:12
Activity of N6-substituted 2-chloroadenosines at A1 and A2 adenosine receptors.
AID33767Functional activity at Adenosine A2A receptor as vasorelaxation of rat aorta1995Journal of medicinal chemistry, Sep-01, Volume: 38, Issue:18
2-[N'-(3-arylallylidene)hydrazino]adenosines showing A2a adenosine agonist properties and vasodilation activity.
AID1508630Primary qHTS for small molecule stabilizers of the endoplasmic reticulum resident proteome: Secreted ER Calcium Modulated Protein (SERCaMP) assay2021Cell reports, 04-27, Volume: 35, Issue:4
A target-agnostic screen identifies approved drugs to stabilize the endoplasmic reticulum-resident proteome.
AID1347154Primary screen GU AMC qHTS for Zika virus inhibitors2020Proceedings of the National Academy of Sciences of the United States of America, 12-08, Volume: 117, Issue:49
Therapeutic candidates for the Zika virus identified by a high-throughput screen for Zika protease inhibitors.
AID1345618Human A2A receptor (Adenosine receptors)2006Nature reviews. Drug discovery, Mar, Volume: 5, Issue:3
Adenosine receptors as therapeutic targets.
AID1345721Human A2B receptor (Adenosine receptors)2006Nature reviews. Drug discovery, Mar, Volume: 5, Issue:3
Adenosine receptors as therapeutic targets.
AID1345721Human A2B receptor (Adenosine receptors)1999Molecular pharmacology, Oct, Volume: 56, Issue:4
Characterization of human A(2B) adenosine receptors: radioligand binding, western blotting, and coupling to G(q) in human embryonic kidney 293 cells and HMC-1 mast cells.
AID1345822Human A3 receptor (Adenosine receptors)1998Naunyn-Schmiedeberg's archives of pharmacology, Jan, Volume: 357, Issue:1
Comparative pharmacology of human adenosine receptor subtypes - characterization of stably transfected receptors in CHO cells.
AID1345618Human A2A receptor (Adenosine receptors)1998Naunyn-Schmiedeberg's archives of pharmacology, Jan, Volume: 357, Issue:1
Comparative pharmacology of human adenosine receptor subtypes - characterization of stably transfected receptors in CHO cells.
AID1345685Human A1 receptor (Adenosine receptors)2005The Journal of pharmacology and experimental therapeutics, Oct, Volume: 315, Issue:1
A novel A1 adenosine receptor antagonist, L-97-1 [3-[2-(4-aminophenyl)-ethyl]-8-benzyl-7-{2-ethyl-(2-hydroxy-ethyl)-amino]-ethyl}-1-propyl-3,7-dihydro-purine-2,6-dione], reduces allergic responses to house dust mite in an allergic rabbit model of asthma.
AID1345822Human A3 receptor (Adenosine receptors)2006Nature reviews. Drug discovery, Mar, Volume: 5, Issue:3
Adenosine receptors as therapeutic targets.
AID1345685Human A1 receptor (Adenosine receptors)2006Nature reviews. Drug discovery, Mar, Volume: 5, Issue:3
Adenosine receptors as therapeutic targets.
AID1345685Human A1 receptor (Adenosine receptors)1999The Journal of biological chemistry, Feb-05, Volume: 274, Issue:6
Identification of the adenine binding site of the human A1 adenosine receptor.
AID1345685Human A1 receptor (Adenosine receptors)1998Naunyn-Schmiedeberg's archives of pharmacology, Jan, Volume: 357, Issue:1
Comparative pharmacology of human adenosine receptor subtypes - characterization of stably transfected receptors in CHO cells.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (243)

TimeframeStudies, This Drug (%)All Drugs %
pre-19902 (0.82)18.7374
1990's96 (39.51)18.2507
2000's97 (39.92)29.6817
2010's41 (16.87)24.3611
2020's7 (2.88)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 11.29

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index11.29 (24.57)
Research Supply Index5.53 (2.92)
Research Growth Index6.83 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (11.29)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews5 (1.98%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other247 (98.02%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]